her2-mutations-guide-hero-banner

Testing for ERBB2/HER2 has paved the way for precision oncology in breast cancer. However, the complexity of HER2 biology is evident in other solid tumor cancers, including non-small cell lung cancer. All three types of HER2 alterations could appear in NSCLC, including mutations, amplifications, and overexpression. HER2 mutations represent distinct oncogenic drivers, and next-generation sequencing is an ideal method for detecting them due to its heterogeneity.

Please fill out this form to download our guide with information about molecular profiling for HER2 mutations in NSCLC.

*
*
*
 
*
*
*
*
 Yes
 No
 I give consent to the Thermo Fisher Scientific group, its affiliates, any of its authorized distributors and agents (“Thermo Fisher Scientific”) to contact me via e-mail, phone calls and other communication methods to inform me of events, services and promotions which Thermo Fisher Scientific believes may be of interest and are useful to me. I am aware that I can withdraw consent by communicating my withdrawal to Thermo Fisher Scientific, including unsubscribing at any time by clicking on the “Unsubscribe” button in any of the emails I receive. I acknowledge that Thermo Fisher will process my Personal Information in accordance with its Privacy Policy.

本網站受 reCAPTCHA 保護，且適用 Google 隱私權政策及服務條款。